Your browser doesn't support javascript.
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects.
Vicenti, Ilaria; Gatti, Francesca; Scaggiante, Renzo; Boccuto, Adele; Zago, Daniela; Basso, Monica; Dragoni, Filippo; Parisi, Saverio Giuseppe; Zazzi, Maurizio.
  • Vicenti I; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Gatti F; Department of Molecular Medicine, University of Padova, Via Gabelli 63, 35121, Padova, Italy.
  • Scaggiante R; Belluno Hospital, Belluno, Italy.
  • Boccuto A; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Zago D; Department of Molecular Medicine, University of Padova, Via Gabelli 63, 35121, Padova, Italy.
  • Basso M; Department of Molecular Medicine, University of Padova, Via Gabelli 63, 35121, Padova, Italy.
  • Dragoni F; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Parisi SG; Department of Molecular Medicine, University of Padova, Via Gabelli 63, 35121, Padova, Italy. saverio.parisi@unipd.it.
  • Zazzi M; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Infection ; 50(2): 541-543, 2022 04.
Article in English | MEDLINE | ID: covidwho-1338293
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine Topics: Vaccines Limits: Humans Language: English Journal: Infection Year: 2022 Document Type: Article Affiliation country: S15010-021-01680-z

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / BNT162 Vaccine Topics: Vaccines Limits: Humans Language: English Journal: Infection Year: 2022 Document Type: Article Affiliation country: S15010-021-01680-z